|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu F, Lin GZ and Zhang JX: An overview of
cancer incidence and trend in China. Chin Cancer. 21:81–85.
2012.
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brawley OW: Avoidable cancer deaths
globally. CA Cancer J Clin. 61:67–68. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang R, Zhang Y, Wen F, Wu K and Zhao S:
Analysis of pathological types and clinical epidemiology of 6,058
patients with lung cancer. Zhongguo Fei Ai Za Zhi. 19:129–135.
2016.(In Chinese). PubMed/NCBI
|
|
6
|
Scott WJ, Howington J, Feigenberg S,
Movsas B and Pisters K: American College of Chest Physicians:
Treatment of non-small cell lung cancer stage I and stage II: ACCP
evidence-based clinical practice guidelines (2nd edition). Chest.
132 3 Suppl:234S–242S. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Woodard GA, Jones KD and Jablons DM: Lung
cancer staging and prognosis. Cancer Treat Res. 170:47–75. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee JH and Chang JH: Diagnostic utility of
serum and pleural fluid carcinoembryonic antigen, neuron-specific
enolase, and cytokeratin 19 fragments in patients with effusions
from primary lung cancer. Chest. 128:2298–2303. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Okamura K, Takayama K, Izumi M, Harada T,
Furuyama K and Nakanishi Y: Diagnostic value of CEA and CYFRA 21-1
tumor markers in primary lung cancer. Lung Cancer. 80:45–49. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin M, Chen J-F, Lu Y-T, Zhang Y, Song J,
Hou S, Ke Z and Tseng H-R: Nanostructure embedded microchips for
detection, isolation, and characterization of circulating tumor
cells. Acc Chem Res. 47:2941–2950. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ilie M, Hofman V, Long-Mira E, Selva E,
Vignaud JM, Padovani B, Mouroux J, Marquette CH and Hofman P:
‘Sentinel’ circulating tumor cells allow early diagnosis of lung
cancer in patients with chronic obstructive pulmonary disease. PLoS
One. 9:e1115972014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen YY and Xu GB: Erratum to: Effect of
circulating tumor cells combined with negative enrichment and
CD45-FISH identification in diagnosis, therapy monitoring and
prognosis of primary lung cancer. Med Oncol. 31:2402014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gorges TM, Penkalla N, Schalk T, Joosse
SA, Riethdorf S, Tucholski J, Lücke K, Wikman H, Jackson S, Brychta
N, et al: Enumeration and molecular characterization of tumor cells
in lung cancer patients using a novel in vivo device for capturing
circulating tumor cells. Clin Cancer Res. 22:2197–2206. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen X, Wang X, He H, Liu Z, Hu JF and Li
W: Combination of circulating tumor cells with serum
carcinoembryonic antigen enhances clinical prediction of non-small
cell lung cancer. PLoS One. 10:e01262762015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hulbert A, Jusue-Torres I, Stark A, Chen
C, Rodgers K, Lee B, Griffin C, Yang A, Huang P, Wrangle J, et al:
Early detection of lung cancer using DNA promoter hypermethylation
in plasma and sputum. Clin Cancer Res. 23:1998–2005. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Iftikhar IH and Musani AI: Narrow-band
imaging bronchoscopy in the detection of premalignant airway
lesions: A meta-analysis of diagnostic test accuracy. Ther Adv
Respir Dis. 9:207–216. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Garg K, Keith RL, Byers T, Kelly K,
Kerzner AL, Lynch DA and Miller YE: Randomized controlled trial
with low-dose spiral CT for lung cancer screening: Feasibility
study and preliminary results. Radiology. 225:506–510. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ettinger DS, Wood DE, Akerley W, Bazhenova
LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA,
Demmy TL, et al: Non-small cell lung cancer, version 1.2015. J Natl
Compr Canc Netw. 12:1738–1761. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Croswell JM, Baker SG, Marcus PM, Clapp JD
and Kramer BS: Cumulative incidence of false-positive test results
in lung cancer screening: A randomized trial. Ann Intern Med.
152(505–512): W176–W180. 2010.
|
|
20
|
Zhi X, Wu Y, Ma S, Wang T, Wang C, Wang J,
Shi Y, Lu Y, Liu L, Liu D, et al: Chinese guidelines on the
diagnosis and treatment of primary lung cancer (2011 version).
Zhongguo Fei Ai Za Zhi. 15:677–688. 2012.(In Chinese). PubMed/NCBI
|
|
21
|
Vallières E, Shepherd FA, Crowley J, Van
Houtte P, Postmus PE, Carney D, Chansky K, Shaikh Z and Goldstraw
P: International Association for the Study of Lung Cancer
International Staging Committee and Participating Institutions: The
IASLC Lung Cancer Staging Project: Proposals regarding the
relevance of TNM in the pathologic staging of small cell lung
cancer in the forthcoming (seventh) edition of the TNM
classification for lung cancer. J Thorac Oncol. 4:1049–1059. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsushima Y, Tateishi U, Uno H, Takeuchi M,
Terauchi T, Goya T and Kim EE: Diagnostic performance of PET/CT in
differentiation of malignant and benign non-solid solitary
pulmonary nodules. Ann Nucl Med. 22:571–577. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hansell DM, Bankier AA, MacMahon H, McLoud
TC, Müller NL and Remy J: Fleischner Society: Glossary of terms for
thoracic imaging. Radiology. 246:697–722. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wood DE: National Comprehensive Cancer
Network (NCCN) Clinical practice guidelines for lung cancer
screening. Thorac Surg Clin. 25:185–197. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gould MK, Fletcher J, Iannettoni MD, Lynch
WR, Midthun DE, Naidich DP and Ost DE: American College of Chest
Physicians: Evaluation of patients with pulmonary nodules: When is
it lung cancer?: ACCP evidence-based clinical practice guidelines
(2nd edition). Chest. 132 3 Suppl:108S–130S. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim YK, Lee SH, Seo JH, Kim JH, Kim SD and
Kim GK: A comprehensive model of factors affecting adoption of
clinical practice guidelines in Korea. J Korean Med Sci.
25:1568–1573. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou Q, Fan Y, Wang Y, Qiao Y, Wang G,
Huang Y, Wang X, Wu N, Zhang G, Zheng X, et al: [China National
Guideline of Classification, Diagnosis and Treatment for Lung
Nodules (2016 version)]. Zhongguo Fei Ai Za Zhi. 19:793–798.
2016.(In Chinese). PubMed/NCBI
|
|
28
|
Swensen SJ, Silverstein MD, Ilstrup DM,
Schleck CD and Edell ES: The probability of malignancy in solitary
pulmonary nodules. Application to small radiologically
indeterminate nodules. Arch Intern Med. 157:849–855. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gould MK, Ananth L and Barnett PG:
Veterans Affairs SNAP Cooperative Study Group: A clinical model to
estimate the pretest probability of lung cancer in patients with
solitary pulmonary nodules. Chest. 131:383–388. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
McWilliams A, Tammemagi MC, Mayo JR,
Roberts H, Liu G, Soghrati K, Yasufuku K, Martel S, Laberge F,
Gingras M, et al: Probability of cancer in pulmonary nodules
detected on first screening CT. N Engl J Med. 369:910–919. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Y, Chen KZ and Wang J: Development and
validation of a clinical prediction model to estimate the
probability of malignancy in solitary pulmonary nodules in Chinese
people. Clin Lung Cancer. 12:313–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wormanns D and Hamer OW: Glossary of terms
for thoracic imaging - German version of the Fleischner Society
Recommendations. ROFO. 187:638–661. 2015.(In German). PubMed/NCBI
|
|
33
|
Ost DE and Gould MK: Decision making in
patients with pulmonary nodules. Am J Respir Crit Care Med.
185:363–372. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Aoki T, Nakata H, Watanabe H, Nakamura K,
Kasai T, Hashimoto H, Yasumoto K and Kido M: Evolution of
peripheral lung adenocarcinomas: CT findings correlated with
histology and tumor doubling time. AJR Am J Roentgenol.
174:763–768. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Patel VK, Naik SK, Naidich DP, Travis WD,
Weingarten JA, Lazzaro R, Gutterman DD, Wentowski C, Grosu HB and
Raoof S: A practical algorithmic approach to the diagnosis and
management of solitary pulmonary nodules: part 2: pretest
probability and algorithm. Chest. 143:840–846. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ost D, Fein AM and Feinsilver SH: Clinical
practice. The solitary pulmonary nodule. N Engl J Med.
348:2535–2542. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Haro A, Yano T, Kohno M, Yoshida T,
Okamoto T and Maehara Y: Ground-glass opacity lesions on computed
tomography during postoperative surveillance for primary non-small
cell lung cancer. Lung Cancer. 76:56–60. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Oda S, Awai K, Murao K, Ozawa A, Yanaga Y,
Kawanaka K and Yamashita Y: Computer-aided volumetry of pulmonary
nodules exhibiting ground-glass opacity at MDCT. AJR Am J
Roentgenol. 194:398–406. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Collisson EA, Campbell JD, Brooks AN,
Berger AH, Lee W, Chmielecki J, Beer DG, Cope L, Creighton CJ,
Danilova L, et al: Cancer Genome Atlas Research Network:
Comprehensive molecular profiling of lung adenocarcinoma. Nature.
511:543–550. 2014. View Article : Google Scholar : PubMed/NCBI
|
